Kolodny J M, Larsen P R, Silva J E
Endocrinology. 1985 May;116(5):2019-28. doi: 10.1210/endo-116-5-2019.
The maximal binding capacity (MBC) of the rat cerebrocortical nuclear T3 receptor, as determined by in vivo saturation techniques, is approximately half that measured in vitro on isolated nuclei or solubilized receptors. To investigate this disparity, the MBC values determined in vivo and in vitro for both rat cerebral cortex and liver were compared, taking into account nuclear receptor loss or inactivation and the presence of endogenous T3. By Scatchard analysis of T3 binding to isolated nuclei in vitro at 37 C, the uncorrected MBC values (mean +/- SEM; n = 3) for the cerebrocortical nuclear T3 receptor in euthyroid and hypothyroid rats were 0.80 +/- 0.14 and 0.66 +/- 0.07 ng T3/mg DNA, respectively, and were not significantly different. The Kd values were also not significantly different (5.6 +/- 0.3 and 5.2 +/- 0.9 X 10(-10) M, respectively). After corrections for incomplete dissociation and receptor inactivation under the in vitro conditions, the overall mean MBC increased by approximately 33% to 0.97 ng T3/mg DNA, or about 3.6 times the in vivo MBC. In addition, cerebrocortical nuclei prelabeled in vivo with +/- 131I]T3 at near-saturating levels and subsequently incubated with [125I]T3 in vitro at concentrations up to 10 times the Kd were shown to bind as much as 4 times more T3 in vitro relative to the amount of endogenous hormone which dissociated, thus exceeding the in vivo MBC by a factor of two. Parallel experiments with isolated liver nuclei did not show the existence of nuclear T3 receptors which were available only in vitro, even when the corrected MBC (0.77 ng T3/mg DNA) was compared with the MBC obtained by the in vivo saturation technique (0.76 ng T3/mg DNA). The experiments with liver nuclei were done at 25 C to reduce the rate of inactivation or loss of nuclear T3 receptors in this tissue. By fractionating isolated cerebrocortical nuclei into neuronal and glial subpopulations on discontinuous sucrose gradients, the high affinity, limited capacity nuclear T3 receptor could only be identified in the neuronal fraction. No consistent specific binding of T3 was observed in glial nuclei that were 80% pure, suggesting that either glial cells in the adult rat are not likely to be direct targets of thyroid hormone or that thyroid hormone may act via nonnuclear receptor-mediated pathways. We conclude that only neurons have specific high affinity, limited capacity nuclear T3 receptors and that as many as half of these receptors may not be accessible to plasma T3.(ABSTRACT TRUNCATED AT 400 WORDS)
通过体内饱和技术测定,大鼠大脑皮质细胞核T3受体的最大结合容量(MBC)约为在体外分离细胞核或可溶性受体上测得值的一半。为研究这种差异,比较了大鼠大脑皮质和肝脏在体内和体外测定的MBC值,同时考虑了核受体的损失或失活以及内源性T3的存在。通过在37℃下对T3与体外分离细胞核的结合进行Scatchard分析,正常甲状腺和甲状腺功能减退大鼠大脑皮质细胞核T3受体未经校正的MBC值(平均值±标准误;n = 3)分别为0.80±0.14和0.66±0.07 ng T3/mg DNA,差异无统计学意义。解离常数(Kd)值也无显著差异(分别为5.6±0.3和5.2±0.9×10⁻¹⁰ M)。在对体外条件下的不完全解离和受体失活进行校正后,总体平均MBC增加了约33%,达到0.97 ng T3/mg DNA,约为体内MBC的3.6倍。此外,在体内用接近饱和水平的[±¹³¹I]T3预先标记的大脑皮质细胞核,随后在体外与浓度高达Kd值10倍的[¹²⁵I]T3孵育,结果显示相对于解离的内源性激素量,其在体外结合的T3多达4倍,因此超过体内MBC两倍。对分离的肝细胞核进行的平行实验未显示仅在体外存在的核T3受体,即使将校正后的MBC(0.77 ng T3/mg DNA)与通过体内饱和技术获得的MBC(0.76 ng T3/mg DNA)进行比较。肝细胞核实验在25℃下进行,以降低该组织中核T3受体的失活或损失速率。通过在不连续蔗糖梯度上对分离的大脑皮质细胞核进行分级分离,将其分为神经元和神经胶质亚群,高亲和力、有限容量的核T3受体仅在神经元部分中被鉴定出来。在纯度为80%的神经胶质细胞核中未观察到一致的T3特异性结合,这表明成年大鼠的神经胶质细胞不太可能是甲状腺激素的直接靶标,或者甲状腺激素可能通过非核受体介导的途径发挥作用。我们得出结论,只有神经元具有特异性高亲和力、有限容量的核T3受体,并且这些受体中多达一半可能无法接触到血浆T3。(摘要截断于400字)